The DOI matches its OpenAlex record; 26 of the 26 references it cites were found in a registry or an index.
Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant
Abstract
Thirty-five patients with the lupus anticoagulant (LA) were followed up between 1975 and 1982. The most prevalent clinical manifestation occurring in these patients was thrombosis. Nineteen patients (54.3%) had a single or recurrent thrombotic episode. Fifteen patients (42.8%) had venous thrombosis, and arterial thrombosis manifested by stroke or transient ischemic attacks occurred in six patients. Bleeding occurred in only five patients, four of whom had severe thrombocytopenia, while no excessive bleeding was noted during 18 operative procedures. Various therapeutic regimens, including corticosteriods, nonsteroidal anti-inflammatory drugs, cytotoxic or immunosuppressive agents, had no effect on the presence of the LA in these patients. Anticoagulants were successful in the treatment and prevention of thrombotic episodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moncada, S., Higgs, E. A., & Vane, J. R. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91655-5 · Cited by 882
Carreras, L., Machin, S., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., & Van Assche, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.
Lafer, E. M., Rauch, J., Andrzejewski, C., Mudd, D., Furie, B., Furie, B., Schwartz, R. S., & Stollar, B. D. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.4.897 · Cited by 536
Acquired inhibitors of blood coagulation.
Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521
(1963) · PubMed · Cited by 512
Thrombosis in Patients with the Lupus Anticoagulant
MUEH, J. R., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 496
Cl, C. (1952) · Journal of Clinical Investigation · Cited by 482
A clinical study of the lupus anticoagulant
Schleider, M., Nachman, R., Jaffe, E., & Coleman, M. (1976) · Blood · doi:10.1182/blood.v48.4.499.499 · Cited by 470
FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT
Lubbe, W. F., Palmer, S. J., Butler, W. S., & Liggins, G. C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92141-4 · Cited by 422
Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.
Gospodarowicz, D., Moran, J., Braun, D., & Birdwell, C. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.4120 · Cited by 414
Thiagarajan, P., Shapiro, S. S., & De Marco, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109869 · Cited by 357
“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation
Carreras, L. O., & Vermylen, J. G. (1982) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657211 · Cited by 295
INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)
Nilsson, I. M., Åstedt, B., Hedner, U., & Berezin, D. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb04897.x · Cited by 293
Circulating anticoagulants: a study of 40 cases and a review of the literature.
Margolius, A., Jackson, D. P., & Ratnoff, O. D. (1961) · PubMed · Cited by 278
Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients
ZARRABI, M. H., ZUCKER, S., MILLER, F., DERMAN, R. M., ROMANO, G. S., HARTNETT, J. A., & VARMA, A. O. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-194 · Cited by 231
Cosgriff, T. M., & Martin, B. A. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240115 · Cited by 166
Laurell, A., & Nilsson, I. M. (1957) · PubMed · Cited by 161
Prekallikrein Inhibition Associated with the Lupus Anticoagulant: A Mechanism of Thrombosis
Sanfelippo, M. J., & Drayna, C. J. (1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/77.3.275 · Cited by 146
Radioimmunological assay of prostaglandin synthetase activity
BAUMINGER, S., Zor, U., & Lindner, H. R. (1973) · Prostaglandins · doi:10.1016/0090-6980(73)90019-1 · Cited by 145
Boxer, M., Ellman, L. L., & Carvalho, A. C. A. (1976) · Arthritis & Rheumatism · doi:10.1002/art.1780190603 · Cited by 145
Carreras, L. O., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb02224.x · Cited by 139
Yin, E. T., & Gaston, L. W. (1965) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1654857 · Cited by 84
Thrombophlebitis in Systemic Lupus Erythematosus
Peck, B. (1978) · JAMA · doi:10.1001/jama.1978.03290160046020 · Cited by 63
A chlorpromazine‐induced inhibitor of blood coagulation
Canoso, R. T., Hutton, R. A., & Deykin, D. (1977) · American Journal of Hematology · doi:10.1002/ajh.2830020209 · Cited by 41
Circulating Anticoagulants in Disseminated Lupus Erythematosus
Medal, L. S., & Lisker, R. (1959) · British Journal of Haematology · doi:10.1111/j.1365-2141.1959.tb04036.x · Cited by 41
Circulating Anticoagulant in Disseminated Lupus Erythematosus
Veltkamp, J. J., Kerkhoven, P., & Loeliger, E. A. (2009) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000214029 · Cited by 39
Cited by
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
“Although a direct causal role for antiphospholipid antibodies in thrombogenesis has not been proved, antiphospholipid antibodies appear to be markers of risk, given the substantially increased rate of thrombosis in patients with these antibodies (6-9, 21, 22).”
BackgroundAnticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Obstetric Complications Associated with the Lupus Anticoagulant
Branch, D. W., Scott, J. R., Kochenour, N. K., & Hershgold, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132104 · Cited by 560
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 543
Metadata
- Authors
- Elias, M. S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1984-03-01
- Volume
- 144
- Issue
- 3
- Pages
- 510-510
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1967602919
- Cited by
- 322
- References
- 26
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.